Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine- induced bronchoconstriction

I. Amirav, R. Yacobov, A. S. Luder (Safed, Haifa, Israel)

Source: Annual Congress 2004 - Therapy in paediatric asthma I
Session: Therapy in paediatric asthma I
Session type: Thematic Poster Session
Number: 1075
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Amirav, R. Yacobov, A. S. Luder (Safed, Haifa, Israel). Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine- induced bronchoconstriction. Eur Respir J 2004; 24: Suppl. 48, 1075

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
More rapid relief of methacholine-induced bronchoconstriction with budesonide/formoterol than with salmeterol/fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 53s
Year: 2001

Formoterol and budesonide/formoterol are both equally as fast and effective as salbutamol in relieving severe acute bronchospasm
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Formoterol turbuhaler as a rescue therapy was as effective and safe as salbutamol by pMDI and spacer in patients with acute severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline
Source: Eur Respir J 2002; 19: 865-871
Year: 2002



Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Formoterol turbuhaler is effective and safe compared with salbutamol by pMDI and spacer as reliever therapy in patients with acute severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler(R) DPI
Source: Eur Respir J 2003; 21: 816-820
Year: 2003



Budesonide 800 μg/day via Easyhaler® is as safe and effective as the same dose of budesonide via Turbuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 100s
Year: 2001

Same minimal effective dose of budesonide Turbuhaler® and fluticasone Diskus®/Accuhaler® in adult asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 158s
Year: 2001

Effect of budesonide/formoterol, budesonide and terbutaline on exercise-induced bronchoconstriction in mild intermittent asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Budesonide and formoterol in a single inhaler is safe and effective in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Reliever effect of extrafine BDP/F DPI in asthmatic patients after methacholine challenge
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018

Device preference and efficacy of formoterol aerolizer and salbutamol MDI in children with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Nebulized salbutamol through the ultrasonic nebulizer during sputum induction improves the bronchoprotection in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Formoterol hydrofluoroalkane (HFA) pMDI has as rapid an onset of action as salbutamol HFA pMDI in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003

Formoterol Turbuhaler as reliever medication in patients with acute asthma
Source: Eur Respir J 2006; 27: 735-741
Year: 2006



Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 307s
Year: 2002